title: Risk factors for delays between intake and veterinary approval for adoption on medical grounds in shelter puppies and kittens.
abstract: To maximize their capacity to save lives and optimize resource allocation, animal shelters need to identify highly adoptable animals that are unlikely to be delayed on medical grounds before they can be made available for adoption. In this retrospective cohort study, our objective was to identify risk factors for delays from intake to approval for adoption on medical grounds in shelter puppies and kittens. Shelter medical records from 2008 for 335 puppies and 370 kittens were selected randomly at a large metropolitan adoption-guarantee shelter. Data including signalment, source shelter, intake veterinary examination findings, clinical history and days from intake until approval by a veterinarian for adoption on medical grounds were extracted from shelter records and analyzed using multivariate Cox regression. Puppies and kittens with clinical signs of respiratory or gastrointestinal disease at intake took significantly longer to receive approval for adoption on medical grounds (puppies - respiratory p<0.0001; gastrointestinal p<0.0001; kittens - respiratory p<0.0001; gastrointestinal p=0.002). Stray kittens were more likely to be delayed than owner-relinquished kittens or those transferred from other shelters (p<0.01). Older kittens were less likely to be delayed (p<0.0001). Administration of oral or parenteral antibiotics to puppies and kittens with respiratory and/or ocular signs within 24h of intake significantly reduced time to approval on medical grounds for adoption (puppies p=0.02; kittens p=0.03). The analyses suggested that puppies and kittens with respiratory or gastrointestinal signs on intake are more likely to experience delays between intake and veterinary approval for adoption on medical grounds. Prompt antimicrobial treatment of animals with respiratory and/or ocular signs may decrease length of stay in the shelter.
authors.affiliation: Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Purdue University, 625 Harrison St., West Lafayette, IN 47907, USA. catvet@purdue.edu
authors.forename: Annette
authors.initials: A
authors.lastname: Litster
authors.forename: Joselyn
authors.initials: J
authors.lastname: Allen
authors.forename: Ahmed
authors.initials: A
authors.lastname: Mohamed
authors.forename: Shuang
authors.initials: S
authors.lastname: He
mesh_terms: D000827:Animal Welfare; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy / Q000453:epidemiology; D002415:Cats; D002641:Chicago / Q000453:epidemiology; D004283:Dog Diseases / Q000188:drug therapy / Q000453:epidemiology; D004285:Dogs; D005767:Gastrointestinal Diseases / Q000188:drug therapy / Q000662:veterinary; D010067:Ownership / Q000706:statistics & numerical data*; D057805:Pets; D016016:Proportional Hazards Models; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000662:veterinary; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents